AKR1C3 and polycystic ovary syndrome: With this minor caveat in mind, our finding of increased AKR1C3 expression and activity confirm and expand the significance of results from a previous study describing increased AKR1C3 messenger RNA expression in subcutaneous adipose tissue of PCOS women (23).